TITLE:
Clinical Efficacy Observation of a Jing Ethnic Prescription in Treating Chronic Atrophic Gastritis
AUTHORS:
Jinjian Xu, Li Wu, Xiaowei He, En Zhao, Tianwu Lai, Man Zhang
KEYWORDS:
Jing Ethnic Prescription, Chronic Atrophic Gastritis, Efficacy, Inflammatory Cytokines
JOURNAL NAME:
International Journal of Clinical Medicine,
Vol.15 No.11,
November
22,
2024
ABSTRACT: Objective: To observe the clinical efficacy of a Jing ethnic prescription in treating chronic atrophic gastritis (CAG). Methods: A total of 182 CAG patients admitted to our hospital were randomly divided into a control group (91 cases) and a treatment group (91 cases) based on their admission order. The control group received conventional treatment, while the treatment group was treated with a Jing ethnic prescription. The clinical efficacy, changes in gastric mucosa-related indicators, and systemic inflammatory markers were compared between the two groups. Results: After treatment, the overall effective rate in the treatment group was higher than that in the control group, but the difference was not statistically significant (P > 0.05). The levels of trefoil factor 2 (TFF2) in the gastric mucosa increased, and the levels of nuclear factor-kappa B (NF-κB) decreased in both groups. However, the improvement in these indicators was significantly better in the treatment group (P Conclusion: The custom formula of the Jing ethnic group shows comparable clinical efficacy to conventional treatment for chronic atrophic gastritis (CAG), but it demonstrates significantly better effects in reducing systemic inflammatory responses. Specifically, the treatment group showed superior results in the following aspects compared to the control group: increased levels of TFF2, decreased levels of NF-κB, and reduced serum levels of IL-6, IL-8, and hs-CRP.